Quality assurance for point-of-care testing of oral anticoagulation: A large-scale evaluation of the Hemochron Junior Signature Microcoagulation System

International Journal of Laboratory Hematology

Volumn 31, Issue 2, 2009, Pages 142-150

  Maddox, J M ^a   Bogo, P H ^a   McGregor, E ^a   Pippard, M J ^a   Kerr, R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Hemochron Junior Signature; Near patient testing; Point of care; Quality assurance; Warfarin

Indexed keywords

ANALYZER; ANTICOAGULATION; ARTICLE; COMMUNITY; HUMAN; HUMAN CELL; INTERNATIONAL NORMALIZED RATIO; MONITORING; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL;

ADMINISTRATION, ORAL; ANTICOAGULANTS; BLOOD COAGULATION TESTS; DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; POINT-OF-CARE SYSTEMS; QUALITY CONTROL; WARFARIN;

EID: 61349100290     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2007.01013.x     Document Type: Article

References (29)

1. Adcock D., Kressin D. Marlar R.A. (1998) The effect of time and temperature variables on routine coagulation tests. Blood Coagulation and Fibrinolysis 9, 463 470.
2. Awad M.A., Selim T.E. Al-Sabbagh F.A. (2004) Influence of storage time and temperature on international normalized ratio (INR) levels and plasma activities of vitamin K dependent clotting factors. Hematology 9, 333 337.
3. Baglin T.P., Cousins D., Keeling D.M., Perry D.J. Watson H.G. (2006) Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency. British Journal of Haematology 136, 26 29.
4. Bereznicki L., Jackson S., Peterson G., Jeffrey E., Marsden K. Jupe D. (2007) Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. Journal of Clinical Pathology 60, 311 314.
5. British Committee for Standards in Haematology General Haematology Taskforce 2007) Guidelines for Point of Care Testing: Haematology. Retrieved 29th October, 2007, from http://www.bcshguidelines.com/pdf/POCT-guidelines- 310707.pdf
6. Chapman D.C., Stephens M.A., Hamann G.L., Bailey L.E. Dorko C.S. (1999) Accuracy, clinical correlation, and patient acceptance of two handheld prothrombin time monitoring devices in the ambulatory setting. Annals of Pharmacotherapy 33, 775 780.
7. Ernst M.E. Brandt K.B. (2003) Evaluation of 4 years of clinical pharmacist anticoagulation case management in a rural, private physician office. Journal of the American Pharmacists Association (Washington DC) 43, 630 636.
8. Fitzmaurice D.A., Hobbs F.D. Murray E.T. (1998) Primary care anticoagulant clinic management using computerized decision support and near patient International Normalized Ratio (INR) testing: routine data from a practice nurse-led clinic. Family Practice 15, 144 146.
9. Fitzmaurice D.A., Hobbs F.D., Murray E.T., Holder R.L., Allan T.F. Rose P.E. (2000) Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial. Archives of Internal Medicine 160, 2343 2348.
10. Fitzmaurice D.A., Murray E.T., Gee K.M. Allan T.F. (2001) Does the Birmingham model of oral anticoagulation management in primary care work outside trial conditions? British Journal of General Practice 51, 828 829.
11. Fitzmaurice D.A., Gardiner C., Kitchen S., Mackie I., Murray E.T. Machin S.J. (2005) An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. British Journal of Haematology 131, 156 165.
12. Froom P., Abramova D., Bar-El M. Barak M. (2001) Reliability of delayed prothrombin time INR determinations in a central laboratory using off-site blood collection. Clinical and Laboratory Haematology 23, 189 192.
13. Gosselin R., Owings J.T., White R.H., Hutchinson R., Branch J., Mahackian K., Johnston M. Larkin E.C. (2000) A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thrombosis and Haemostasis 83, 698 703.
14. Kitchen S., Kitchen D.P., Jennings I., Woods T.A., Walker I.D. Preston F.E. (2006) Point-of-care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors. Thrombosis and Haemostasis 96, 590 596.
15. Lafata J.E., Martin S.A., Kaatz S. Ward R.E. (2000) The cost-effectiveness of different management strategies for patients on chronic warfarin therapy. Journal of General Internal Medicine 15, 31 37.
16. Loebstein R., Kurnik D., Lubetsky A., Ezra D. Halkin H. (2003) Potential dosing errors using portable prothrombin time monitoring devices. Blood Coagulation and Fibrinolysis 14, 479 483.
17. Medical Devices Agency of UK Department of Health. (2002) Medical Devices Agency device Bulletin MDA DB2002(03). Hannibel House, London.
18. Near Patient Testing Working Party, General Haematology Task Force of BCSH, Thrombosis and Haemostasis Task Force of BCSH 1995) Guidelines for near patient testing: Haematology. Clinical and Laboratory Haematology 17, 301 310.
19. Nowatzke W.L., Landt M., Smith C., Wilhite T., Canter C. Luchtman-Jones L. (2003) Whole blood international normalization ratio measurements in children using near-patient monitors. Journal of Pediatric Hematology and Oncology 25, 33 37.
20. Parry D., Fitzmaurice D. Raftery J. (2000) Anticoagulation management in primary care: a trial-based economic evaluation. British Journal of Haematology 111, 530 533.
21. Pell J., McIver B., Stuart P., Malone D. Alcock J. (1993) Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic. British Journal of General Practice 43, 152 154.
22. Pierce M.T., Crain L., Smith J. Mehta V. (2000) Point-of-care versus laboratory measurement of the international normalized ratio. American Journal of Health-System Pharmacy 57, 2271 2274.
23. Radley A. (1995) Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. Journal of Clinical Pathology 48, 545 547.
24. Rao L.V., Okorodudu A.O., Petersen J.R. Elghetany M.T. (2000) Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions. Clinina Chimica Acta 300, 13 21.
25. Shiach C.R., Campbell B., Poller L., Keown M. Chauhan N. (2002) Reliability of point-of-care prothrombin time testing in a community clinic: a randomised crossover comparison with hospital laboratory testing. British Journal of Haematology 119, 370 375.
26. Sunderji R., Gin K., Shalansky K., Carter C., Chambers K., Davies C., Schwartz L. Fung A. (2005) Clinical impact of point-of-care vs laboratory measurement of anticoagulation. Americal Journal of Clinical Pathology 123, 184 188.
27. Taborski U., Braun S.L. Voller H. (2004) Analytical performance of the new coagulation monitoring system INRatio for the determination of INR compared with the coagulation monitor Coaguchek S and an established laboratory method. Journal of Thrombosis and Thrombolysis 18, 103 137.
28. Woods K., Douketis J.D., Schnurr T., Kinnon K., Powers P. Crowther M.A. (2004) Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thrombosis Research 114, 161 165.
29. Yamreudeewong W., Johnson J.V., Cassidy T.G. Berg J.T. (1996) Comparison of two methods for INR determination in pharmacist-based oral anticoagulation clinic. Pharmacotherapy 16, 1159 1165.